Oral Administration of Buparvaquone Nanostructured Lipid Carrier Enables in Vivo Activity Against Leishmania Infantum
European Journal of Pharmaceutical Sciences(2021)
Key words
Buparvaquone,Nanostructured lipid carrier,Leishmaniasis,Neglected diseases
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined